NCT06836427

CMTS0929 for Clostridioides Difficile Infection

CMTS0929 for Clostridioides Difficile Infection: a Prospective, Open-label, Single-arm Clinical Study

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: The Second Hospital of Nanjing Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, open-label, single-arm study to explore the safety and the efficacy of CMTS0929 for patients with Clostridioides difficile infection (CDI).

Detailed description

At least 12 subjects who meet all the inclusion criteria but do not meet any exclusion criteria will be enrolled in this study. Data of demographic characteristics and clinical data will be collected. After treatment, they will enter the follow-up period for safety and efficacy evaluation.

Conditions

• Clostridioides Difficile Infection

Interventions

Type	Name	Description
BIOLOGICAL	CMTS0929	CMTS0929 is defined as suspension from washed microbiota.

Timeline

• Start date: 2025-02-20
• Primary completion: 2030-01-31
• Completion: 2030-07-01
• First posted: 2025-02-20
• Last updated: 2025-02-20

Locations

1 site across 1 country: China